Filing Details

Accession Number:
0000078003-23-000052
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-03-23 16:14:26
Reporting Period:
2023-03-17
Accepted Time:
2023-03-23 16:14:26
Original Submission Date:
2023-03-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1782223 Pyxis Oncology Inc. PYXS Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
78003 Pfizer Inc 66 Hudson Boulevard East
New York NY 10001-2192
No No Yes No
1776087 Pfizer Ventures (Us) Llc 66 Hudson Boulevard East
New York NY 10001-2192
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2023-03-17 1,811,594 $2.76 5,952,263 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The securities were issued under that certain first amendment dated March 16, 2023 to the Amended and Restated License Agreement dated October 14, 2022 between the Reporting Person and the Issuer, pursuant to which the Issuer agreed to issue to the Reporting Person such number of shares of common stock equivalent to $5.0 million at a per share price equal to the closing price of the Issuer's common stock on the business day when the closing price of the Issuer's common stock on the Nasdaq Global Select Market is at or above $2.46 per share on any day between March 16, 2023 and a date that is within 180 days following October 6, 2022.
  2. On March 17, 2023, the closing price of the Issuer's common stock on the Nasdaq Global Select Market was $2.76 per share.